Outcomes of Ribavirin Free Treatment of Recurrent Genotype 1, Hepatitis C Infection Post Liver Transplant.

被引：0
|
作者：
Jones, D. [1 ]
Baggett, S. [1 ]
Shoreibah, M. [2 ]
Massoud, O. [2 ]
机构：
[1] UAB Hosp, Dept Pharm, Birmingham, AL USA
[2] UAB Hosp, Dept Gastroenterol, Birmingham, AL USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2016年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
D285
引用
收藏
页码：790 / 790
页数：1
相关论文
共 50 条
  • [21] Pegylated interferon α-2b plus ribavirin in the treatment of post-liver transplant recurrent hepatitis C
    Ross, AS
    Bhan, AK
    Pascual, M
    Thiim, M
    Cosimi, AB
    Chung, RT
    [J]. CLINICAL TRANSPLANTATION, 2004, 18 (02) : 166 - 173
  • [22] Hepatitis C Genotype 1 Treatment Response And Outcomes Utilizing Combination Therapy With Telaprevir, Pegylated Interferon Alfa 2a And Ribavirin In Liver Transplant Recipients With Recurrent Cirrhosis
    Bhamidimarri, Kalyan R.
    Peyton, Adam
    Aye, Lydia
    Copado, Violet
    Junaidi, Omer
    Levy, Cynthia
    Martin, Paul
    Rudraraju, Madhavi
    [J]. HEPATOLOGY, 2013, 58 : 1164A - 1164A
  • [23] Early predictors of antiviral treatment response in liver transplant recipients with recurrent hepatitis C genotype 1
    Campos-Varela, I.
    Esteban, J. I.
    Bes, M.
    Caralt, M.
    Allende, H.
    Rodriguez-Frias, F.
    Salcedo, M. T.
    Sauleda, S.
    Charco, R.
    Guardia, J.
    Esteban, R.
    Castells, L.
    [J]. JOURNAL OF VIRAL HEPATITIS, 2014, 21 (10) : E118 - E128
  • [24] Treatment of recurrent hepatitis C virus infection after liver transplantation with interferon and ribavirin
    Götz, G
    Schön, MR
    Haefker, A
    Neuhaus, R
    Berg, T
    Hopf, U
    Neuhaus, P
    [J]. TRANSPLANTATION PROCEEDINGS, 1998, 30 (05) : 2104 - 2106
  • [25] High sustained virological response to pegylated interferon and ribavirin for recurrent genotype 3 hepatitis C infection post-liver transplantation
    Nabiha Faisal
    Khalid Mumtaz
    Max Marquez
    Eberhard L. Renner
    Leslie B. Lilly
    [J]. Hepatology International, 2015, 9 : 76 - 83
  • [26] High sustained virological response to pegylated interferon and ribavirin for recurrent genotype 3 hepatitis C infection post-liver transplantation
    Faisal, Nabiha
    Mumtaz, Khalid
    Marquez, Max
    Renner, Eberhard L.
    Lilly, Leslie B.
    [J]. HEPATOLOGY INTERNATIONAL, 2015, 9 (01) : 76 - 83
  • [27] Zenapax and effect on clinical outcome of hepatitis C post liver transplant.
    Islam, KK
    Rustgi, VK
    Kuo, PC
    Plotkin, JS
    Kim, K
    Johnson, LB
    [J]. GASTROENTEROLOGY, 2000, 118 (04) : A995 - A995
  • [28] Ribavirin treatment facilitates weaning from immunosuppression in liver transplant recipients with recurrent hepatitis C
    Tisone, G
    Zazza, S
    Manzia, TM
    Ciceroni, C
    De Luca, L
    Angelico, M
    Casciani, CU
    [J]. LIVER TRANSPLANTATION, 2003, 9 (06) : C5 - C5
  • [29] Treatment of Recurrent Hepatitis C in Liver Transplant Recipients With Extended Duration of Pegylated Interferon and Ribavirin
    Arrigo, Richard
    Samanta, Arun
    Griffith, Shanthini
    Parekh, Ravish M.
    Korogodsky, Maria
    Rao, Kiran V.
    Fisher, Adrian
    Wilson, Dorian
    Klein, Kenneth M.
    Koneru, Baburao
    [J]. GASTROENTEROLOGY, 2011, 140 (05) : S459 - S459
  • [30] Successful treatment of post liver transplant patients with genotype 1 hepatitis C virus with sofosbuvir and simeprevir
    Punzalan, Carmi S.
    Barry, Curtis
    Zacharias, Isabel
    Rodrigues, Julie
    Mehta, Savant
    Bozorgzadeh, Adel
    Barnard, Graham
    [J]. HEPATOLOGY, 2014, 60 : 688A - 688A
12345